1. Home
  2. Stock quotes
  3. Anika Therapeutics
  4. Financial Statements
  5. Income Statement
Anika Therapeutics logo
Anika Therapeutics ANIK
$ 16.51 1.1%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Anika Therapeutics Income Statement 2011-2024 | ANIK

Annual Income Statement Anika Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

 373 M 406 M 458 M 526 M 606 M 548 M 994 M 730 M 562 M 575 M 472 M 141 M 119 M

Shares

 14.7 M 14.6 M 14.4 M 14.2 M 14.1 M 14.4 M 14.6 M 14.7 M 14.9 M 14.7 M 14.1 M 13.3 M 13.1 M

Historical Prices

 25.4 27.9 31.8 37 41.1 38 66.7 50.5 37.6 39.2 33.3 10.6 9.2

Net Income

 -82.7 M -14.9 M 4.13 M -24 M 27.2 M 18.7 M 31.8 M 32.5 M 30.8 M 38.3 M 20.6 M 11.8 M 8.47 M

Revenue

 167 M 156 M 148 M 130 M 115 M 106 M 113 M 103 M 93 M 106 M 75.1 M 71.4 M 64.8 M

Cost of Revenue

 63.6 M 62.7 M 64.9 M 61.4 M 28.7 M 31.3 M 27.4 M 24 M - - - - -

Gross Profit

 103 M 93.6 M 82.9 M 69 M 85.9 M 74.3 M 86.1 M 79.4 M 71.9 M 84.7 M 52.3 M 42.4 M 38 M

Operating Income

 -87.6 M -19.4 M 2.62 M -28.3 M 34.2 M 21.7 M 45.7 M 50.6 M 48.1 M 61.4 M 32.6 M 19.7 M 14 M

Interest Expense

 - - - - - - - - - - - - -

EBITDA

 -81.2 M -12.7 M 9.1 M -22.2 M 40.2 M 27.7 M 50 M 54.3 M 51.9 M 66.2 M 37.1 M 26.8 M 18 M

Operating Expenses

 - - - - 51.6 M 52.5 M 40.3 M 28.7 M 23.8 M 23.2 M 20 M 20.1 M 24 M

General and Administrative Expenses

 95.8 M 84.8 M 74.1 M 60.1 M 35 M 34.3 M 21.5 M 18 M 14.8 M 15.1 M 12.9 M 14.7 M 17.9 M

All numbers in USD currency

Quarterly Income Statement Anika Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

 14.8 M 14.8 M 14.7 M 14.7 M 14.6 M 14.7 M 14.7 M 14.6 M 14.6 M 14.6 M 14.5 M 14.4 M 14.4 M 14.4 M 14.3 M 14.3 M 14.2 M 14.2 M 14.2 M 14.3 M 14.1 M 13.9 M 14.2 M 14.2 M 14.2 M 14.7 M 14.7 M 14.7 M 14.6 M 14.6 M 14.6 M 14.6 M 14.6 M 14.7 M 14.9 M 15 M 15 M 15 M 14.9 M 14.9 M 14.8 M 14.7 M 14.5 M 14.3 M 13.7 M 13.5 M 13.4 M 13.3 M 13.3 M 13.3 M 13.2 M 13.1 M 12.8 M 12.7 M 12.7 M

Net Income

 -29.9 M -88 K -4.51 M - -6.58 M -2.74 M -10.4 M - -4.18 M -2.84 M -2.93 M - 558 K 6.53 M 2.84 M -15.7 M -6.41 M -7.71 M 5.79 M 4.05 M 9.2 M 9.44 M 4.51 M 7.72 M 7.6 M 10.1 M -6.69 M 8.07 M 6.89 M 11.4 M 5.49 M 8.08 M 8.95 M 8.62 M 6.9 M 11 M 8.38 M 7.82 M 3.52 M 7.82 M 6.17 M 9.3 M 15 M 6.65 M 4.96 M 5.89 M 3.07 M 4.46 M 1.65 M 3.74 M 1.91 M 2.88 M 2.98 M 2.28 M 324 K

Revenue

 38.8 M 41.9 M 40.5 M - 41.5 M 44.3 M 37.9 M - 40.3 M 39.7 M 36.7 M - 39.5 M 38.1 M 34.3 M 32.7 M 31.7 M 30.7 M 35.4 M 29.8 M 29.7 M 30.4 M 24.7 M 27 M 26.8 M 30.5 M 21.3 M 29.4 M 27.2 M 33.5 M 23.4 M 28.7 M 25.8 M 26.6 M 22.3 M 30.9 M 23.7 M 22.9 M 15.5 M 23.3 M 22.1 M 26.3 M 34 M 21.3 M 17.8 M 20.8 M 15.2 M 22.6 M 14.8 M 19.6 M 14.4 M 18.4 M 18.5 M 16.1 M 11.7 M

Cost of Revenue

 37.3 M 14.6 M 15.9 M - 16.5 M 15.3 M 15.1 M - 17.5 M 14.8 M 14.9 M - 16.5 M 17.3 M 13.3 M - 14.4 M 16.9 M 14.2 M 8.65 M 5.95 M 6.84 M 7.31 M 7 M 8.28 M 8.15 M 7.84 M 8.72 M 6.25 M 6.32 M 6.08 M - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

 1.44 M 27.4 M 24.6 M - 24.9 M 29 M 22.8 M - 22.8 M 24.9 M 21.8 M - 23 M 20.8 M 21 M 16.7 M 17.3 M 13.7 M 21.2 M 21.1 M 23.7 M 23.6 M 17.4 M 19.9 M 18.5 M 22.4 M 13.4 M 20.2 M 20.9 M 22 M 17.3 M 20.8 M 20.8 M 20.5 M 16.9 M 19.3 M 18.5 M 17.6 M 11.2 M 12.4 M 16.2 M 15.9 M 9.99 M 14 M 11.6 M 13.8 M 9.65 M 14.2 M 6.83 M 10.8 M 7.2 M 10.6 M 10.4 M 8.76 M 5.46 M

Operating Income

 -28 M 161 K -5.06 M - -7.67 M -3.63 M -12.6 M - -5.8 M -3.38 M -3.55 M - 1.3 M 9.18 M 1.26 M - -7.93 M -9.54 M 7.09 M - 12 M 11.9 M 5.48 M - 8.57 M 11.2 M -7.83 M - 10.3 M 17.7 M 8.01 M - 13.7 M 13.5 M 10.7 M - 13.1 M 12.4 M 5.5 M - 10.3 M 15.2 M 23.9 M - 7.77 M 9.4 M 5.01 M - 2.73 M 6.13 M 3.06 M - 4.82 M 3.68 M 557 K

Interest Expense

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

 -27.7 M 561 K -3.33 M - -5.77 M -1.63 M -10.9 M - -814 K -1.48 M -1.88 M - 6 M 11.2 M 2.8 M - -3.38 M -3.08 M 9.86 M - 16.5 M 14.9 M 6.96 M - 13 M 14.2 M -6.36 M - 13.5 M 19.7 M 9.02 M - 16.5 M 15.4 M 11.7 M - 15.9 M 14.3 M 6.42 M - 13.9 M 17.6 M 25.1 M - 11.3 M 11.7 M 6.21 M - 6.09 M 8.32 M 4.05 M - 7.76 M 5.62 M 1.48 M

Operating Expenses

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

 19.1 M 19.8 M 21.5 M - 24.8 M 23.7 M 27 M - 21.3 M 21.3 M 19.2 M - 17.5 M 18 M 18.2 M - 15.9 M 14.6 M 14.4 M - 7.54 M 7.5 M 7.67 M - 5.7 M 6.42 M 16.1 M - 4.82 M 4.97 M 5.07 M - 4.28 M 4.26 M 3.99 M - 3.31 M 3.39 M 3.6 M - 4.04 M 3.87 M 3.49 M - 3.19 M 3.4 M 3.95 M - 3.6 M 4.11 M 3.35 M - 4.71 M 4.23 M 4.04 M

All numbers in USD currency